Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 4Withdrawn 2Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Thyroid Neoplasms 2Hypothyroidism 2Goiter 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Triiodothyronine × Clear all
NCT04782856 2024-06-14

Energy Metabolism in Thyroidectomized Patients

Virginia Commonwealth University

Phase 2 Completed
13 enrolled 10 charts
Head & Neck

Goiter, Hypothyroidism, Thyroid Neoplasms

NCT00223158 2014-04-09

Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

Université de Sherbrooke

Phase NA Completed
70 enrolled
Head & Neck

Hypothyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡